Wellness Daily Nauru: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Daily Nauru.

Press releases published on July 8, 2026

Jul. 8, 2026

NOMAD Increases Voyager Fleet Energy Storage by up to 56%, Bringing Eagle and Falcon to 2.025 MWh

Indeterminate GlobeNewswire

Jul. 8, 2026

Monogram Health Announces Renewed NCQA Case Management Accreditation for Three Years

Indeterminate GlobeNewswire

Jul. 8, 2026

UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer

Indeterminate GlobeNewswire

Jul. 8, 2026

ORYZON Announces U.S. Patent Grant for Vafidemstat in Borderline Personality Disorder (BPD)

Indeterminate GlobeNewswire

Jul. 8, 2026

Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026

Indeterminate GlobeNewswire

Jul. 8, 2026

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months

Indeterminate GlobeNewswire

Jul. 8, 2026

Ontario’s Lung Cancer Screening Program Ranks Among World’s Best, but Half of Patients Are Still Diagnosed at Advanced Stages, New Report Finds

Indeterminate GlobeNewswire

Jul. 8, 2026

Conavi Medical Announces JSCAI Publication Demonstrating the Clinical Utility of Hybrid IVUS OCT Imaging

Indeterminate GlobeNewswire

Jul. 8, 2026

BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities

Indeterminate GlobeNewswire

Jul. 8, 2026

Upfront Diagnostics Announces Global Medical Advisory Board to Accelerate Efforts in Reducing Time to Stroke Care

Indeterminate GlobeNewswire

Jul. 8, 2026

Shopify to Announce Second-Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 8, 2026

Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment

Indeterminate GlobeNewswire

Jul. 8, 2026

Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees

Indeterminate GlobeNewswire

Jul. 8, 2026

OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain

Indeterminate GlobeNewswire

Jul. 8, 2026

J-Star Holding Holding Co., Ltd Announces 1-for-5 Share Consolidation

Indeterminate GlobeNewswire

Jul. 8, 2026

Nonprofit Launches One of the Nation’s Most Comprehensive Education Resources for Inherited Retinal Diseases

Indeterminate GlobeNewswire

Jul. 8, 2026

AMSilk and Ajinomoto Foods Europe Expand Partnership to Enable Industrial-Scale Production of Silk Proteins

Indeterminate GlobeNewswire

Jul. 8, 2026

Dumbo Health Launches SleepLongevityAge, Bringing Clinical Care to the World’s Most Overlooked Health Metric

Indeterminate GlobeNewswire

Jul. 8, 2026

Tensive appoints Peter Crosby Chairman as its bioresorbable breast reconstruction scaffold approaches regulatory approval

Indeterminate GlobeNewswire

Jul. 8, 2026

LincNutri Launches NAD+ Supplement for Women, Expanding Its Healthy Aging Portfolio with Multi-Ingredient Cellular Support

Indeterminate GlobeNewswire